Category: Metabolic & Obesity Care

AT A GLANCE Eli Lilly reports Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity. Karen Kaplan at the Los Angeles Times rightly notes ‘…doctors who treat obesity… fear the medications are making this health disparity worse.’ Is the Era of ‘Brozempic’ Upon Us? asks The New York Times, with reports of some telehealth start-ups ‘…playing up

Hello all, I hope everyone is having a terrific weekend! We are quite excited here at twenty30 health, as we will be attending the annual conference of the American Society of Metabolic and Bariatric Surgery (ASMBS) in Las Vegas this week, in force; see more below. We look forward to connecting with colleagues and friends, old and new, whilst there. It

AT A GLANCE The 30th European Congress on Obesity [or ECO] was held in Dublin, Ireland this past week, with keynote sessions and scientific presentations. Omada Health, Found Health and Virta Health, synchronously announced their direct-to-employer offerings on care for people with obesity, in a clear call from employers on the cost and long-term durability of GLP-1 medications. Medicare coverage of obesity treatments, and the potential cost implications if Medicare covers

AT A GLANCE… World Health Organization’s says Wegovy and other weight-loss drugs are ‘…not a silver bullet.’ A seeming shift in the narrative this week toward multimodal, whole-person, and multi-year strategies of care; challenging current direct to consumer, medication-first approaches. Benjamin Chavis Jr., an African-American civil rights leader, writes in The Miami Times on ‘Obesity is not a hopeless fight for Black America.’ Researchers in Scotland find that

AT A GLANCE… Plezi Nutrition, a kids juice drink company, was launched by former First Lady Michelle Obama this week; Ms. Obama is the prior architect of the Let’s Move program. Jenny Craig, a forty year old, nutrition-forward weight loss company with over 1,000 stores, formally announced ‘…It’s with a heavy heart, we’re announcing the close of our business.’ The American Association of Clinical

AT A GLANCE… GLP-1 drugs continue to hit the headlines, with United Health Group CEO Andrew Witty weighing in on their benefit and usage. Pregnancy risks of GLP-1 meds – very low likelihood, though currently unknown beyond animal studies. Teledoc strides into GLP-1 space; and Ro founder Zachariah Reitano publishes a long piece on the scientific basis of obesity management with respect to GLP-1 medications. Bariatric surgery reviewed for treatment

AT A GLANCE… Calibrate, a telehealth GLP-1 prescription machine, reports an 18% reduction in workforce, with a move to employer-based contracts. Legacy weight loss companies focused upon behavior change, counting calories and low-carb diets are in a quandary whether to embrace anti-obesity medications. Prediabetes currently affects 1 in 3 adult Americans and is projected to impact over one billion people across the globe by 2045. More

I wish everyone a Happy Easter if you celebrate and happy weekend if you do not :) AT A GLANCE… Beyond BMI – a high-profile academic committee gets together this week to debate and define the role of BMI as a measure of obesity and health. The U.S. military is struggling with recruitment and lost workdays of their soldiers due to challenges with managing obesity. Two